GnRH agonist triggering: Recent developments

Reproductive BioMedicine Online

Volumn 26, Issue 3, 2013, Pages 226-230

  Kol, Shahar ^a   Humaidan, Peter ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

FSH surge; GnRH agonist; LH surge; OHSS; oocyte maturation; ovulation triggering

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; PROGESTERONE;

HORMONE ACTION; HUMAN; LUTEAL PHASE; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PATIENT COMFORT; REVIEW; RISK ASSESSMENT;

CHORIONIC GONADOTROPIN; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEAL PHASE; LUTEINIZING HORMONE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; REPRODUCTIVE CONTROL AGENTS; RISK FACTORS;

EID: 84875368093     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.11.002     Document Type: Review

References (36)

1. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, M. Gal, B. Brooks, T. Mimoni, and T. Eldar-Geva Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum. Reprod. 21 2006 1260 1265
2. C. Benadiva, and L. Engmann Intensive luteal phase support after GnRH agonist trigger: it does help Reprod. Biomed. Online 25 2012 329 330
3. M.L. Bonduelle, R. Dodd, I. Liebaers, A. Van Steirteghem, R. Williamson, and R. Akhurst Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes Hum. Reprod. 3 1988 909 914
4. D.D. Braat, J.M. Schutte, R.E. Bernardus, T.M. Mooij, and F.E. van Leeuwen Maternal death related to IVF in the Netherlands 1984-2008 Hum. Reprod. 25 2010 1782 1786
5. M. Cerrillo, S. Rodríguez, M. Mayoral, A. Pacheco, J. Martínez-Salazar, and J.A. Garcia-Velasco Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction Fertil. Steril. 91 Suppl. 4 2009 1526 1528
6. Confidential Enquiry into Maternal and Child Health, 2007. Saving mothers' lives: reviewing maternal deaths to make motherhood safer 2003-2005. VIIth report.
7. J. de Mouzon, V. Goossens, S. Bhattacharya, J.A. Castilla, A.P. Ferraretti, V. Korsak, M. Kupka, K.G. Nygren, and A.N. Andersen Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE Hum. Reprod. 27 2012 954 966
8. P. Devroey, N.P. Polyzos, and C. Blockeel An OHSS-free clinic by segmentation of IVF treatment Hum. Reprod. 26 2011 2593 2597
9. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil. Steril. 89 2008 84 91
10. European Recombinant LH Study Group Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group J. Clin. Endocrinol. Metab. 83 1998 1507 1514
11. B.C. Fauser, and P. Devroey Reproductive biology and IVF: ovarian stimulation and luteal phase consequences Trends Endocrinol. Metab. 4 2003 236 242
12. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J. Clin. Endocrinol. Metab. 71 1990 918 922
13. G. Griesinger, L. Schultz, T. Bauer, A. Broessner, T. Frambach, and S. Kissler Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin- releasing hormone antagonist protocol in combination with a 'freeze-all' strategy: a prospective multicentric study Fertil. Steril. 95 2011 2029 2033
14. D. Griffin, C. Benadiva, N. Kummer, T. Budinetz, J. Nulsen, and L. Engmann Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders Fertil. Steril. 97 2012 1316 1320
15. E.R. Hernández, J.L. Gómez-Palomares, and E. Ricciarelli No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles Fertil. Steril. 91 Suppl. 4 2009 1358 1361
16. J.D. Hoff, M.E. Quigley, and S.S. Yen Hormonal dynamics at midcycle: a reevaluation J. Clin. Endocrinol. Metab. 57 1983 792 796
17. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod. Biomed. Online 18 2009 630 634
18. P. Humaidan, and N.P. Polyzos (Meta)analyze this: systematic reviews might lose credibility Nat. Med. 18 2012 1321
19. P. Humaidan, L. Bungum, M. Bungum, and C. Yding Andersen Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod. Biomed. Online 13 2006 173 178
20. P. Humaidan, H. Ejdrup Bredkjaer, L.G. Westergaard, and C. Yding Andersen 1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
21. P. Humaidan, S. Kol, E.G. Papanikolaou on behalf of the 'The Copenhagen GnRH Agonist Triggering Workshop Group' GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum. Reprod. Update 17 2011 510 524
22. P. Humaidan, E.G. Papanikolaou, D. Kyrou, B. Alsbjerg, N.P. Polyzos, P. Devroey, and H.M. Fatemi The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives Reprod. Biomed. Online 24 2012 134 141
23. P. Humaidan, S. Kol, L. Engmann, C. Benadiva, E.G. Papanikolaou, and C.Y. Andersen Should Cochrane reviews be performed during the development of new concepts? Hum. Reprod. 27 2012 6 8
24. Humaidan, P., Alsbjerg, B., Mikkelsen, A.L., Elbaek, H., Erb, K., Papanikolaou, E.G., Andersen, C.Y., submitted for publication. GnRHa trigger and luteal phase hCG support according to ovarian response to stimulation in IVF patients - A prospective randomized controlled multi-centre study. Hum. Reprod.
25. T. Imbar, S. Kol, F. Lossos, Y. Bdolah, A. Hurwitz, and R. Haimov-Kochman Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support Hum. Reprod. 27 2012 753 759
26. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil. Steril. 56 1991 213 220
27. S. Kol Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome Fertil. Steril. 81 2004 1 5
28. S. Kol, and P. Humaidan LH (as hCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango Reprod. Biomed. Online 21 2010 590 592
29. S. Kol, P. Humaidan, and J. Itskovitz-Eldor GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study Hum. Reprod. 26 2011 2874 2877
30. R. Orvieto Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help? Reprod. Biomed. Online 24 2012 680 681
31. R. Orvieto, J. Rabinson, S. Meltzer, E. Zohav, E. Anteby, and R. Homburg Substituting HCG with GnRH agonist to trigger final follicular maturation-a retrospective comparison of three different ovarian stimulation protocols Reprod. Biomed. Online 13 2006 198 201
32. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, H.M. Fatemi, A. Van Steirteghem, and P. Devroey Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil. Steril. 85 2006 112 120
33. B. Radesic, and K. Tremellen Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates Hum. Reprod. 26 2011 3437 3442
34. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and S. Thomas Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization Fertil. Steril. 90 2008 231 233
35. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of 'triggers' using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil. Steril. 95 2011 2715 2717
36. Youssef, M.A., Van der Veen, F., Al-Inany, H.G., Griesinger, G., Mochtar, M.H., Aboulfoutouh, I., Khattab, S.M., van Wely, M., 2011. Gonadotropin- releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst. Rev., CD008046.